Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia
- PMID: 21840365
- DOI: 10.1016/j.pnpbp.2011.07.014
Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia
Abstract
Objective: Metabolic adversities are prevalent in patients with schizophrenia. Retinol-binding protein 4 (RBP4) and high molecular weight (HMW) adiponectin have been recently found to be associated with metabolic features in non-psychiatric population. The study aimed to evaluate the associations between metabolic features and RBP4, total adiponectin, and HMW adiponectin in patients with schizophrenia.
Methods: We recruited 109 patients with schizophrenia treated with clozapine or haloperidol and evaluated their body mass index (BMI), waist circumference, blood pressure, and fasting triglyceride (TG), high-density lipoprotein cholesterol (HDL-C), fasting plasma glucose, insulin, RBP4, total adiponectin, and HMW adiponectin levels.
Results: We found that patients with metabolic syndrome (MS) had higher RBP4 level, and lower total adiponectin and HMW adiponectin levels than those without MS. There were no significant differences in metabolic features and adipocytokine levels between patients treated with clozapine and haloperidol. Most of the metabolic indexes were significantly correlated with the levels of adipocytokines. After adjusting the effects of age, gender, and BMI, marginal significant correlations existed between TG and RBP4 levels; HDL-C and total adiponectin and HMW adiponectin; insulin and HOMA-IR and HMW adiponectin. Receiver operating curve analysis showed that all of the three adipocytokines could differentiate patients with MS from those without MS. Meanwhile, total adiponectin and HMW adiponectin, but not RBP4, had the differentiating power for insulin resistance.
Conclusion: Higher RBP4 and lower total adiponectin and HMW adiponectin levels were observed in schizophrenic patients with MS. Only HMW adiponectin is marginally correlated with insulin sensitivity. The finding that metabolic profiles, but not the antipsychotic types, are associated with adipocytokine levels should be confirmed in longitudinal studies.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Association of plasma retinol-binding protein 4, adiponectin, and high molecular weight adiponectin with insulin resistance in non-diabetic hypertensive patients.Yonsei Med J. 2010 May;51(3):375-84. doi: 10.3349/ymj.2010.51.3.375. Yonsei Med J. 2010. PMID: 20376890 Free PMC article.
-
Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients.Arch Physiol Biochem. 2010 May;116(2):57-62. doi: 10.3109/13813451003631421. Arch Physiol Biochem. 2010. PMID: 20222849
-
Relationship of adipokines (adiponectin, resistin and RBP4) with metabolic syndrome components in pubertal obese children.Biomark Med. 2013 Jun;7(3):423-8. doi: 10.2217/bmm.13.14. Biomark Med. 2013. PMID: 23734806
-
Serum high-molecular-weight adiponectin as a marker for the evaluation and care of subjects with metabolic syndrome and related disorders.J Atheroscler Thromb. 2010 Dec 26;17(12):1201-11. doi: 10.5551/jat.6106. Epub 2010 Oct 8. J Atheroscler Thromb. 2010. PMID: 20948162 Review.
-
[The role of adiponectin in pathogenesis of insulin resistance and metabolic syndrome].Pol Merkur Lekarski. 2005 Nov;19(113):723-6. Pol Merkur Lekarski. 2005. PMID: 16498821 Review. Polish.
Cited by
-
The Role of Adiponectin in the Pathogenesis of Metabolic Disturbances in Patients With Schizophrenia.Front Psychiatry. 2021 Jan 20;11:605124. doi: 10.3389/fpsyt.2020.605124. eCollection 2020. Front Psychiatry. 2021. PMID: 33551872 Free PMC article. Review.
-
Molecular Mechanisms of Antipsychotic Drug-Induced Diabetes.Front Neurosci. 2017 Nov 21;11:643. doi: 10.3389/fnins.2017.00643. eCollection 2017. Front Neurosci. 2017. PMID: 29209160 Free PMC article. Review.
-
A novel biomarker of cardiometabolic pathology in schizophrenia?J Psychiatr Res. 2019 Oct;117:31-37. doi: 10.1016/j.jpsychires.2019.06.011. Epub 2019 Jun 18. J Psychiatr Res. 2019. PMID: 31276836 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous